Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine, as well as offers insulin aspart regular and biphasic drug products. Further, the company offers delivery devices for insulin, including DispoPen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Low
1,086.70
High
2,422.30
Low
1,830.00
High
1,898.80
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Wockhardt Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | WOCKPHARMA Wockhardt Limited | 1,888.00 | 3.14% | 75.00 | 25.17 | 30,745 | 0.00% | 6.43% | 2,422.30 / 1,086.70 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 418.00 | 0.78% | 19.97 | 20.93 | 3,815 | 5.53% | 20.38% | 534.55 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 816.10 | 1.59% | 34.73 | 23.50 | 7,400 | 13.69% | 14.28% | 946.10 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,250.00 | 0.50% | 34.55 | 759.88 | 55,774 | 0.00% | 0.00% | 32,900.00 / 25,150.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 14.38 | 0.07% | 5.93 | 2.42 | 764 | 0.00% | 58.02% | 17.27 / 9.08 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,650.00 | 0.24% | 40.18 | 90.83 | 45,595 | 0.00% | 30.87% | 3,796.00 / 2,329.90 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 750.00 | 0.39% | 39.37 | 19.05 | 11,483 | 9.97% | 35.62% | 775.00 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,357.00 | 0.95% | 27.68 | 49.03 | 16,506 | 0.00% | 28.10% | 1,418.00 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,395.00 | 0.09% | 29.90 | 180.45 | 64,536 | 2.73% | 7.93% | 5,933.50 / 5,075.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 533.25 | 2.22% | 28.56 | 18.67 | 1,541 | 0.38% | 23.27% | 790.95 / 482.80 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 818.75 | 0.57% | 23.22 | 35.27 | 16,150 | 0.15% | 20.51% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 7,400.00 | 1.43% | 109.07 | 67.85 | 18,500 | 0.00% | 18.49% | 9,849.50 / 7,371.50 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,614.90 | 0.43% | 25.23 | 64.00 | 92,918 | 4.09% | 41.78% | 1,682.40 / 1,016.10 |